Icosavax Inc (DELISTED) (ICVX:DL)
15.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 29, 16:00
Icosavax Cash from Financing (Quarterly): -0.208M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.208M |
| June 30, 2023 | 68.07M |
| March 31, 2023 | 0.117M |
| December 31, 2022 | 10.09M |
| September 30, 2022 | -0.279M |
| June 30, 2022 | 0.223M |
| March 31, 2022 | 0.276M |
| December 31, 2021 | 0.26M |
| Date | Value |
|---|---|
| September 30, 2021 | 191.50M |
| June 30, 2021 | -0.767M |
| March 31, 2021 | 113.78M |
| December 31, 2020 | 1.71M |
| September 30, 2020 | 4.862M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.066M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.767M
Minimum
Jun 2021
191.50M
Maximum
Sep 2021
25.98M
Average
0.26M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 19.87M |
| Immunogen Inc (DELISTED) | 32.13M |
| AbbVie Inc | 10.82B |
| Assure Holdings Corp | -0.177M |
| Harpoon Therapeutics Inc (DELISTED) | 2.032M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.97M |
| Cash from Investing (Quarterly) | -72.65M |
| Free Cash Flow | -76.31M |
| Free Cash Flow Per Share (Quarterly) | -0.3798 |
| Free Cash Flow Yield | -11.32% |